Omega Fund Management as of March 31, 2023
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group Common Stock (REPL) | 35.1 | $54M | 3.1M | 17.66 | |
| Nuvation Bio Common Stock Class A (NUVB) | 16.3 | $25M | 15M | 1.66 | |
| Morphic Holding Common Stock (MORF) | 14.7 | $23M | 598k | 37.64 | |
| Alpine Immune Sciences Common Stock | 10.2 | $16M | 2.0M | 7.72 | |
| Ikena Oncology Common Stock (IKNA) | 5.1 | $7.8M | 2.2M | 3.45 | |
| Theseus Pharmaceuticals Common Stock | 4.1 | $6.3M | 712k | 8.88 | |
| Kronos Bio Common Stock (KRON) | 3.6 | $5.6M | 3.8M | 1.46 | |
| Paratek Pharmaceuticals Common Stock | 3.3 | $5.0M | 2.0M | 2.54 | |
| Spruce Biosciences Common Stock (SPRB) | 3.1 | $4.8M | 2.2M | 2.21 | |
| Sana Biotechnology Common Stock (SANA) | 1.8 | $2.8M | 844k | 3.27 | |
| Immunic Common Stock (IMUX) | 1.7 | $2.7M | 1.8M | 1.49 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.4 | $671k | 251k | 2.67 | |
| Jounce Therapeutics Common Stock | 0.3 | $510k | 276k | 1.85 | |
| Senti Biosciences Common Stock (SNTI) | 0.2 | $231k | 196k | 1.18 |
